This is confusing. I reread the PR a few times and
Post# of 148282
(Total Views: 456)
Posted On: 02/01/2020 9:25:06 AM
This is confusing. I reread the PR a few times and thought I understood that we had data from 3 mTNBC patients and one IND patient, but now I’m unsure given NP’s response.
I believe someone needs to send NP a follow up email with the short statements from the PR that Techguru posted and ask NP to clarify (showing that the PR says we have 3 mTNBC patients and 1 IND patient). I want to believe he misspoke in the email to Trading and that CYDY didn’t make that big of a mistake in the PR.
I believe someone needs to send NP a follow up email with the short statements from the PR that Techguru posted and ask NP to clarify (showing that the PR says we have 3 mTNBC patients and 1 IND patient). I want to believe he misspoke in the email to Trading and that CYDY didn’t make that big of a mistake in the PR.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼